Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient

Pediatr Dev Pathol. 2020 May-Jun;23(3):240-246. doi: 10.1177/1093526619889130. Epub 2019 Nov 18.

Abstract

Atypical and malignant lipomatous tumors are infrequent in the pediatric population. Within this uncommon cohort, the morphologically and genetically related spectrum of atypical lipomatous tumor/well-differentiated liposarcoma/dedifferentiated liposarcoma (ALT/WDL/DDLS) is markedly rare. Their shared characteristic molecular aberration is a genomic amplicon of a region of chromosome 12q, including the oncogenes MDM2 and CDK4. We present an unusual case of a pediatric patient with an ALT, with recurrence after 2 years in the form of a bone-forming mass, radiologically and pathologically mimicking parosteal osteosarcoma, a tumor also molecularly characterized by amplification of MDM2 and CDK4. However, with ample histologic sampling, a single focus of lipogenic differentiation was identified, thus representing the first near complete low-grade osteosarcomatous dedififferentation reported within ALT/WDL/DDLS and the first ever in pediatric patient. The case serves a reminder of a diagnosis differential and pitfalls within MDM2-amplified tumors.

Keywords: MDM2; atypical lipomatous tumor; liposarcoma; osteosarcoma.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Cell Dedifferentiation
  • Diagnosis, Differential
  • Female
  • Gene Amplification
  • Humans
  • Liposarcoma / diagnosis*
  • Liposarcoma / genetics
  • Liposarcoma / pathology*
  • Neoplasm Grading
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm Recurrence, Local / genetics
  • Neoplasm Recurrence, Local / pathology*
  • Osteosarcoma / diagnosis*
  • Proto-Oncogene Proteins c-mdm2 / genetics
  • Soft Tissue Neoplasms / diagnosis
  • Soft Tissue Neoplasms / genetics
  • Soft Tissue Neoplasms / pathology

Substances

  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2